Grant: Discovery Grants Program - Individual
Université Laval
$34,000.00
Role of NTPDase1 and extracellular nucleotides in smooth muscle cell contraction
EF 2015-16
Résumé
Nucleotides (ATP, ADP, UTP and UDP) are released in a regulated manner by cells and tissues such as smooth muscle cells (SMC) and nerves innervating SMC. Once outside the cell, these molecules activate specific P2-receptors. The hydrolysis of ATP and ADP to adenosine by ectonucleotidases terminates the latter's effects and causes the activation of adenosine (or P1) receptors which often results in different physiological effects to those elicited by P2-receptor activation. We recently demonstrated that NTPDase1 was the dominant ectonucleotidase in vascular SMC and that mice deficient in NTPDase1 unmasked a major vasoconstrictor effect of nucleotides via P2Y6. More recently we observed that NTPDase1 was expressed in non-vascular SMC of the vas deferens and that its activity was necessary to prevent P2X1 functionality. The absence of NTPDase1 in vas deferens led to impaired peristalsis, reduced spermatozoa concentration in the semen, and reduced fertility. We therefore hypothesize that NTPDase1 is the major ectonucleotidase at the surface of SMC in all organs and that its presence affects contraction via the regulation of the P2 receptor agonist levels. We also hypothesize that NTPDase1 can limit the activation of some receptors while its presence may be necessary to prevent some other nucleotide receptors from desensitization. To evaluate our hypotheses, we have designed the following objectives.
Obj 1: Determine whether non-vascular SMC express ectonucleotidase activity, and if so, identify the enzyme(s).
Obj 2: Evaluate the role of the ectonucleotidase(s) identified in Obj 1 in smooth muscle (SM) contraction.
Obj 3: Identify the P2 receptors involved in the regulation of SM contraction.
Obj 1 will be done by enzyme histochemistry of tissue section from SM containing tissues such as those from the respiratory tract, the reproductive tract and the gastrointestinal tract. Immunohistochemistry, quantitative RT-PCR and Western blot will identify the ectonucleotidase present in these SM. Obj 2 will be done by the comparison of isometric contraction of WT tissues with tissues from mice deficient for the ectonucleotidase identified in the first objective and also by assessing calcium mobilization in primary SMC cultures under different stimuli including exogenous ATP, ADP, UTP and UDP. The identification of the P2 receptors involved in SM contraction observed in the 2nd objective will be evaluated in the 3rd objective with several tools including pharmacological antagonists and KO mice deficient for the P2 receptor candidate suggested by the former experiments.
In this work we expect to define a basic mechanism of non-vascular smooth muscle contraction involving ectonucleotidases and different P2 receptors. In this work we will identify the ectonucleotidase involved in smooth muscle contraction as well as the nucleotide (P2) receptors.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2015-06580
Name nom
Sévigny, Jean
Department département
Microbiologie-infectiologie et d'immunologie - Microbiologie-infectiologie et d'
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
1
Application title
Role of NTPDase1 and extracellular nucleotides in smooth muscle cell contraction
Keyword
NSERC
Application summary
<p>Nucleotides (ATP, ADP, UTP and UDP) are released in a regulated manner by cells and tissues such as smooth muscle cells (SMC) and nerves innervating SMC. Once outside the cell, these molecules activate specific P2-receptors. The hydrolysis of ATP and ADP to adenosine by ectonucleotidases terminates the latter's effects and causes the activation of adenosine (or P1) receptors which often results in different physiological effects to those elicited by P2-receptor activation. We recently demonstrated that NTPDase1 was the dominant ectonucleotidase in vascular SMC and that mice deficient in NTPDase1 unmasked a major vasoconstrictor effect of nucleotides via P2Y6. More recently we observed that NTPDase1 was expressed in non-vascular SMC of the vas deferens and that its activity was necessary to prevent P2X1 functionality. The absence of NTPDase1 in vas deferens led to impaired peristalsis, reduced spermatozoa concentration in the semen, and reduced fertility. We therefore hypothesize that NTPDase1 is the major ectonucleotidase at the surface of SMC in all organs and that its presence affects contraction via the regulation of the P2 receptor agonist levels. We also hypothesize that NTPDase1 can limit the activation of some receptors while its presence may be necessary to prevent some other nucleotide receptors from desensitization. To evaluate our hypotheses, we have designed the following objectives.</p>
<p>Obj 1: Determine whether non-vascular SMC express ectonucleotidase activity, and if so, identify the enzyme(s).<br />
Obj 2: Evaluate the role of the ectonucleotidase(s) identified in Obj 1 in smooth muscle (SM) contraction.<br />
Obj 3: Identify the P2 receptors involved in the regulation of SM contraction.</p>
<p>Obj 1 will be done by enzyme histochemistry of tissue section from SM containing tissues such as those from the respiratory tract, the reproductive tract and the gastrointestinal tract. Immunohistochemistry, quantitative RT-PCR and Western blot will identify the ectonucleotidase present in these SM. Obj 2 will be done by the comparison of isometric contraction of WT tissues with tissues from mice deficient for the ectonucleotidase identified in the first objective and also by assessing calcium mobilization in primary SMC cultures under different stimuli including exogenous ATP, ADP, UTP and UDP. The identification of the P2 receptors involved in SM contraction observed in the 2nd objective will be evaluated in the 3rd objective with several tools including pharmacological antagonists and KO mice deficient for the P2 receptor candidate suggested by the former experiments.</p>
<p>In this work we expect to define a basic mechanism of non-vascular smooth muscle contraction involving ectonucleotidases and different P2 receptors. In this work we will identify the ectonucleotidase involved in smooth muscle contraction as well as the nucleotide (P2) receptors. <br />
<br />
</p>